Metraipolis › archive › dc_dfda70900d2f

Neoadjuvant Chemotherapy With Gemcitabine/Cisplatin/S-1 for Resectable Biliary Tract Cancer With FDG-PET-Positive Lymph Node Metastasis (KHBO1201): A… — Europe PMC PMID:41243312

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41243312
DOI
10.1002/jhbp.70030
License (as archived)
solo-consultazione
Archived
2026-11-08T13:01:37.221Z
SHA-256 of the archived text
bb59e73e169a6be88b49ceb2e486e3076d68eefbdbaafeef5961cdc5774538f7
Stable URL of this page
https://metraipolis.com/documento/dc_dfda70900d2f

How to cite

Neoadjuvant Chemotherapy With Gemcitabine/Cisplatin/S-1 for Resectable Biliary Tract Cancer With FDG-PET-Positive Lymph Node Metastasis (KHBO1201): A… — Europe PMC PMID:41243312 — Europe PMC (en), https://europepmc.org/article/MED/41243312 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dfda70900d2f (Metraipolis archive dc_dfda70900d2f, sha256 bb59e73e169a6be88b49ceb2e486e3076d68eefbdbaafeef5961cdc5774538f7)
BibTeX
@misc{dcdfda70900d2f,
  title = {Neoadjuvant Chemotherapy With Gemcitabine/Cisplatin/S-1 for Resectable Biliary Tract Cancer With FDG-PET-Positive Lymph Node Metastasis (KHBO1201): A… — Europe PMC PMID:41243312},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41243312},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dfda70900d2f; sha256 bb59e73e169a6be88b49ceb2e486e3076d68eefbdbaafeef5961cdc5774538f7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41243312. Agents can read the archived copy with the MCP tool read_document.